JACQUELINE HIRTH to Papillomaviridae
This is a "connection" page, showing publications JACQUELINE HIRTH has written about Papillomaviridae.
Connection Strength
2.596
-
Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014). Vaccine. 2019 07 09; 37(30):4040-4046.
Score: 0.617
-
Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26?year old females in the U.S. Vaccine. 2018 Nov 29; 36(50):7682-7688.
Score: 0.592
-
Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old). Vaccine. 2017 06 14; 35(27):3446-3451.
Score: 0.535
-
Compliance with cervical cancer screening and human papillomavirus testing guidelines among insured young women. Am J Obstet Gynecol. 2013 Sep; 209(3):200.e1-7.
Score: 0.407
-
Human papillomavirus dose reminder preferences among parents from a diverse clinical sample: a qualitative study. Hum Vaccin Immunother. 2022 12 31; 18(1):2031697.
Score: 0.186
-
Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014. Obstet Gynecol. 2017 10; 130(4):693-701.
Score: 0.137
-
Prevalence of Oral Human Papillomavirus Infection: Impact of Sex, Race/Ethnicity, and Vaccination Status. Clin Infect Dis. 2022 04 09; 74(7):1230-1236.
Score: 0.047
-
Prevalence of Genital Human Papillomavirus by Age and Race/Ethnicity Among Males. Clin Infect Dis. 2021 11 02; 73(9):1625-1633.
Score: 0.046
-
Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years). Hum Vaccin Immunother. 2015; 11(10):2337-44.
Score: 0.028